BioWorld

Jan. 9, 2009

View Archived Issues

Anadys Soars 115 percent on Strong Hepatitis C Virus Data

Read More

Senate HELP Committee Grills Daschle about Health Reform

Read More

Vivaldi Raises $23M Financing for Older Adult Flu Vaccines

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Pharma Still Keen for Vaccines; Wyeth, Crucell in Merger Talks

Dutch vaccines maker Crucell NV confirmed that it was talking to Wyeth about a possible merger after reports surfaced Wednesday afternoon that the big pharma firm was interested in an acquisition. (BioWorld Today) Read More

Plexxikon Rejoins with Roche in $335M Deal for Raf Inhibitors

Read More